E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Phase 1/2 Completed
224 enrolled 15 charts
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
Phase 1/2 Completed
8 enrolled 20 charts
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
Phase 1 Completed
26 enrolled 24 charts
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
Phase 1 Completed
12 enrolled 12 charts
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Completed
190 enrolled 12 charts
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
Phase 2 Completed
77 enrolled 17 charts
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 Completed
45 enrolled 30 charts
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Phase 2 Completed
348 enrolled 15 charts
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
Phase 3 Completed
1 enrolled 1 chart
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
Phase 1/2 Completed
27 enrolled 16 charts
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
Phase 1 Completed
58 enrolled 17 charts
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Phase 2 Completed
47 enrolled 14 charts
PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
Phase 1/2 Completed
24 enrolled 20 charts
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
Phase 1/2 Completed
93 enrolled 27 charts
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
Phase 2 Completed
86 enrolled 16 charts
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Completed
54 enrolled 10 charts
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
Phase NA Completed
20 enrolled
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
Completed
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
Phase 1 Completed
50 enrolled
Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia
Phase NA Completed
120 enrolled
High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer
Phase 2 Completed
33 enrolled
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
Phase 1 Completed
40 enrolled
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
Phase NA Completed
120 enrolled
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma
Phase 1 Completed
64 enrolled
Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast
Phase NA Completed
60 enrolled
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Phase NA Completed
Gefitinib in Treating Patients With Cervical Cancer
Phase 2 Completed
Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection
Phase NA Completed
24 enrolled
EF5 in Treating Patients With Solid Tumors
Phase 1 Completed
50 enrolled
ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer
Phase 1 Completed
23 enrolled
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
Completed
100 enrolled
Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
Phase 1 Completed
240 enrolled